Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1183699694
总结
CYP2C19 normal metabolizers are associated with decreased risk of major adverse cardiac events when treated with clopidogrel in people with Coronary Artery Disease as compared to CYP2C19 poor metabolizers and intermediate metabolizers.